FIELD : biotechnology.SUBSTANCE : invention refers to biotechnology and medicine, namely to producing an angioprotective and nootropic agent in the form of a solid dosage form for oral administration. Method involves separate granulation of 150–600?mg of troxerutin and 5–10?mg of vinpocetine by mixing each of them with a filler selected from polyethylene glycol-6000, sorbitol or mixtures thereof, until homogeneous, mixing with 1–5?% binder solution, selected from sodium salt of carboxymethyl starch, polyethylene oxide, followed by drying in a fluidised bed at temperature of 100?°C, after which the obtained granules are powdered with at least one antifriction agent, such as aerosil, tween-80, magnesium stearate, and pressed to obtain a solid dosage form.EFFECT : invention widens the range of equipment.3 cl, 2 tbl, 4 ex